Novavax Receives Full Marketing Authorization for Prototype COVID-19 Vaccine Nuvaxovid™ ▼ in United Kingdom

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the Medicines...

Related Keywords

Mexico ,South Africa ,United Kingdom ,Erika Schultz ,Johnc Jacobs ,Ali Chartan ,Novavax Inc ,Administration Of Nuvaxovid ,Regulatory Agency ,Nasdaq ,Exchange Commission ,Google Play Or Apple App ,Linkedin ,Chief Executive Officer ,Google Play ,Apple App ,Safety Information ,Product Characteristics ,Package Leaflet ,New England Journal ,Financial Condition ,Annual Report ,Quarterly Reports ,Novavax ,Nc ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Biotechnology ,Clinical Trials Amp Medical Discoveries ,